Literature DB >> 3523879

Multivariate analysis of risk factors in cadaver donor kidney transplantation.

F Sanfilippo, W K Vaughn, W M LeFor, E K Spees.   

Abstract

Data collected prospectively on 3811 kidney transplants performed between June 1977 and July 1982 with follow-up to July 1984 by the 42 member institutions of the South-Eastern Organ Procurement foundation were analyzed to identify factors associated with graft and patient outcome in patients not receiving cyclosporine. Multivariate Cox regression analysis was used to examine the association and relative risk of 24 variables with three actuarial outcomes: overall graft failure, irreversible rejection, and patient death. Factors having no suggested association with any outcome included: recipient sex, history of pregnancy, blood group, and time on dialysis; organ preservation method, time and source; donor race; crossmatch test sensitivity; and annual center transplant rate. In decreasing order of relative risk, the factors most significantly associated with irreversible rejection were: loss of two or more prior grafts, low HLA-A,B match, lack of pretransplant blood transfusion, high (greater than 60%) pretransplant sensitization to leukocyte (HLA) antigens, and delayed graft function. Splenectomy, insulin-dependent diabetes, and antilymphocyte serum therapy provided the greatest risk of patient death. Factors such as recipient age, race, and native nephrectomy had suggested associations with outcome. By adding each center as a separate covariate in the analysis, other center-dependent factors were quantitated and found in some cases to have a highly significant association with graft and patient outcome. These results provide a basis for evaluating the potential risk of graft loss or patient death for those prospective cadaver kidney transplant recipients not being considered for cyclosporine therapy.

Entities:  

Mesh:

Year:  1986        PMID: 3523879     DOI: 10.1097/00007890-198607000-00006

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Revisiting traditional risk factors for rejection and graft loss after kidney transplantation.

Authors:  T B Dunn; H Noreen; K Gillingham; D Maurer; O G Ozturk; T L Pruett; R A Bray; H M Gebel; A J Matas
Journal:  Am J Transplant       Date:  2011-08-03       Impact factor: 8.086

2.  Risk Stratification for Rejection and Infection after Kidney Transplantation.

Authors:  Pietro E Cippà; Marc Schiesser; Henrik Ekberg; Teun van Gelder; Nicolas J Mueller; Claude A Cao; Thomas Fehr; Corrado Bernasconi
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-01       Impact factor: 8.237

3.  Subgroup analyses in randomized controlled trials: the need for risk stratification in kidney transplantation.

Authors:  M Wagner; E M Balk; D M Kent; B L Kasiske; H Ekberg
Journal:  Am J Transplant       Date:  2009-10       Impact factor: 8.086

4.  Important risk factors of allograft survival in cadaveric renal transplantation. A study of 426 patients.

Authors:  A G Diethelm; E H Blackstone; D C Naftel; S L Hudson; W H Barber; M H Deierhoi; B O Barger; J J Curtis; R G Luke
Journal:  Ann Surg       Date:  1988-05       Impact factor: 12.969

5.  Kidney Transplant Recipients With Primary Membranous Glomerulonephritis Have a Higher Risk of Acute Rejection Compared With Other Primary Glomerulonephritides.

Authors:  Tripti Singh; Brad Astor; Weixiong Zhong; Didier Mandelbrot; Arjang Djamali; Sarah Panzer
Journal:  Transplant Direct       Date:  2017-10-18

6.  The Effect of Transplant Volume and Patient Case Mix on Center Variation in Kidney Transplantation Outcomes.

Authors:  Anne Tsampalieros; Dean Fergusson; Stephanie Dixon; Shane W English; Douglas Manuel; Carl Van Walraven; Monica Taljaard; Greg A Knoll
Journal:  Can J Kidney Health Dis       Date:  2019-09-20

7.  Center Variation and the Effect of Center and Provider Characteristics on Clinical Outcomes in Kidney Transplantation: A Systematic Review of the Evidence.

Authors:  Anne Tsampalieros; Gregory A Knoll; Nicholas Fergusson; Alexandria Bennett; Monica Taljaard; Dean Fergusson
Journal:  Can J Kidney Health Dis       Date:  2017-10-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.